期刊文献+

IL-10对CVB3病毒性心肌炎治疗作用的研究 被引量:2

Therapeutic effect of interleukin-10 on viral myocarditis
下载PDF
导出
摘要 目的 探讨外源性的白介素(IL)-10对柯萨奇B3病毒(CVB3)性心肌炎小鼠治疗作用的机制.方法 将84只Balb/c小鼠随机分为正常组、感染组和治疗组.感染组和治疗组用CVB3感染Balb/c小鼠制备病毒性心肌炎小鼠模型,然后治疗组给予重组小鼠(m)IL-10治疗5天,正常组和感染组在同一时间腹腔注射磷酸盐缓冲溶液,观察小鼠发病及死亡情况,在不同时间段,测定小鼠心肌病毒滴定度、病理积分及心肌组织中IL-2与肿瘤坏死因子的表达,并进行比较.结果 3组小鼠的生存率(χ2=10.562,P〈0.01)、不同时期病理积分(F=3.587~5.794,均P〈0.01)及心肌IL-2和肿瘤坏死因子-α的表达均具有显著性差异(均P〈0.01).感染组和治疗组心肌病毒滴度无明显差异(F=8.389,P〉0.05).结论 IL-10不能降低心肌病毒滴度,但能减少心肌组织中IL-2和肿瘤坏死因子-α的表达,对早期病毒性心肌炎有治疗作用. Objective To investigate the therapeutic effect of interleukin-10 (IL-10) on viral myocarditis (VMC) induced by Coxsackie virus B3 ( CVB3 ). Methods 84 Balb/c infected mice were randomly divided into three groups: normal group, infection group and treatment group. The VMC mouse models in infection group and treatment group were prepared by inoculating Balb/c mice with CVB3. Then mIL-10 was administered for 5 days in treatment group, and daily phosphate buffered solution (PBS) was injected intraperitoneally in normal group and infection group at the same time. The morbidity and mortality of mice were observed. Virus titer in myocardial tissue, pathological score and the expressions of IL-2 and tumor necrosis factor (TNF) were measured at different periods and made comparison among them. Results There were significant differences in survival rate (χ2 = 10. 562, P 〈 0.01 ), pathological score of different period ( F = 3. 587- 5.794, P〈0.01) and the expressions of IL-2 and TNF-α among three groups (all P 〈 0.01 ). The difference.in virus titer between infection group and treatment group was not significant (F = 8. 389, P 〉 0.05). Conclusion Although IL-10 cannot reduce the virus titer of the heart, it can decrease the expressions of IL-2 and TNF-α in myocardial tissue, and it has therapeutic effect on VMC at early stage.
出处 《中国妇幼健康研究》 2011年第5期576-578,共3页 Chinese Journal of Woman and Child Health Research
关键词 病毒性心肌炎 治疗 白介素-10 肿瘤坏死因子-α 白介素-2 viral myocarditis (VMC) treatment interleukin-10 ( IL-10 ) tumor necrosis factor-or (TNF-α) interleukin-2 ( IL-2 )
  • 相关文献

参考文献5

  • 1Rezkalla S,Kloner R N,Khatib G,et al.Effect of metoprolol on the acute phase of Coxsackievirus B3 murine myocarditis[J].J Am Coil Cardiol,1988,12(8):412-414.
  • 2吴凡,邱汉婴.细胞因子与病毒性心肌炎研究进展[J].汕头大学医学院学报,2002,15(4):246-248. 被引量:3
  • 3Matsumori A,Sasayama S.The role of infammatory mediators in the failing heart:Immunomodulation of cytokines in experimental models of heart failure[J].Heart Fail Rev,2001,6(2):129-136.
  • 4Fuse K,Kodama M,Okura Y,et al.Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis[J].Eur J Heart Fail,2005,7(1):109-112.
  • 5Hofmann P,Schmidtke M,Stelzner A,et al.Suppression of proinflammatory cytokines and induction of lL-10 in human monocytes after coxsackievirus B3 infection[J].Med Virol,2001,64(4):487-498.

二级参考文献16

  • 1Yoshinori S,Naoyuki T,Hideo Y et al.Expression of cytokine mRNA in murine hearts with acute myocarditis caused by coxsackievirus B3[J].Journal Of Pathology,1997,183:105-108
  • 2Andreas H,Carsten M,Hans S et al. Coxsackie virus B3-induced production of tumor necrosis factor-α, IL-1β and IL-6 in human monocytes[J].The Journal Of Immunology,1992,148:2270-2275
  • 3Testsuo S,Akira M,Shigetake S.Persistent expression of cytikine in the chronic stage of viral myocarditis in mice[J].Circulation,1996,94:2930-2937
  • 4Kishimoto C,Kuroki Y,Hiraoka Y et al.Cytokine and murine coxsackie myocarditis:interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage[J].Circulation,1994,89:2836-2842
  • 5Gerhard G,Christian LP,Ivan H et al.Induction of autoimmune myocarditis in interleukin-2-deficient mice[J].Circulation,1997,95:1773-1776
  • 6Fiorentino DF,Bond MW,Mosmann TR.Two types of mouse Thelper cell:Th2 clones secrete a factor that inhibits cytokine production by Th1 clones[J].J Excep Med,1989,170:2081-2095
  • 7Ryosuke N,Akira M,Testsuo S et al.Treatment of experimental viral myocarditis with interleukin-10[J].Circulation,1999,100:1102-1108
  • 8Siegener MS,Heim A,Figulla HR.Subclassification of dila- ted cardiomyopathy and interferon treatment[J].Eur Heart J,1995,16(Suppl O):147-149
  • 9Miric M,Miskovic A,Vasiljevic JD et al.Interferon and thymic homones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy[J].Eur Heart J,1995,16(Suppl O):150-152
  • 10Norimi Y,Masafumi S,Motohiro O et al.Effect of intranasal administration of recombinant murine interferon-γ on murine acute myocarditis caused by encephalomyocarditis virus[J].Circulation,1998,97:1017-1023

共引文献2

同被引文献15

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部